The Future: A Pediatric Perspective

  • Ronald J. Hogg
  • Abdalla Rifai
  • Judy B. Splawski
  • Robert J. Wyatt
Chapter
Part of the Topics in Renal Medicine book series (TIRM, volume 2)

Abstract

Since an unfavorable clinical outcome is now expected for a significant percentage of IgA nephropathy patients [1–9], the demonstration of factors that are associated with the development of end-stage renal disease will be an important area of investigation in the next few years. In order to understand whether risk factors that are identified in adult patients will be important for the pediatric patient, it is necessary to consider the differences in expression of clinical disease that exist between adult and pediatric patients.

Keywords

Macroscopic Hematuria Pediatric Perspective Southwest Pediatric Nephrology Study Group 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.
This is a preview of subscription content, log in to check access.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Droz D: Natural history of primary glomerulonephritis with mesangial deposits of IgA. Contrib Nephrol 2:150–157, 1976.Google Scholar
  2. 2.
    Van der Peet J, Arisz L, Brentjens JRH, Marrink J, Hoedemaeker P: The clinical course of IgA nephropathy in adults. Clin Nephrol 8:335–340, 1977.PubMedGoogle Scholar
  3. 3.
    Clarkson AR, Seymour AE, Thompson AJ, Haynes WDG, Chan Y-L, Jackson B: IgA nephropathy: a syndrome of uniform morphology, diverse clinical features and uncertain prognosis. Clin Nephrol 8:459–471, 1977.PubMedGoogle Scholar
  4. 4.
    Berger J, Yaneva H, Crosnier J: La glomerulonéphrite à dépôts mésangiaux d’IgA: une cause frequente d’insuffisance renal terminale. Nouv Presse Med 9:219–21, 1980.PubMedGoogle Scholar
  5. 5.
    Wyatt RJ, Julian BA, Bhathena DB, Mitchell BL, Holland NH, Malluche HH: IgA nephropathy: presentation, clinical course and prognosis in children and adults. Am J Kidney Dis 4:192–200, 1984.PubMedGoogle Scholar
  6. 6.
    D’Amico G, Imbasciati E, Barbiano di Belgioioso G, Bertoli S, Fogazzi G, Ferrario F, Fellin G, Ragni A, Colasanti G, Minetti L, Ponticelli C: Idiopathic IgA mesangial nephropathy: clinical and histological study of 374 patients. Medicine 64:49–60, 1985.PubMedGoogle Scholar
  7. 7.
    Levy M, Beaufils H, Gubler MC, Habib R: Idiopathic recurrent macroscopic hematuria and mesangial IgA-IgG deposits in children (Berger’s disease). Clin Nephrol 2:63–69, 1973.Google Scholar
  8. 8.
    Michalk D, Waldherr R, Seelig HP, Weber HP, Scharer K: Idiopathic mesangial IgA-glomerulonephritis in childhood: description of 19 pediatric cases and review of the literature. Eur J Pediatr 134:13–22, 1980.PubMedCrossRefGoogle Scholar
  9. 9.
    Kitajima T, Murakami M, Sakai O: Clinicopathological features in the Japanese patients with IgA nephropathy. Jpn J Med 22:219–222, 1983.PubMedCrossRefGoogle Scholar
  10. 10.
    Southwest Pediatric Nephrology Study Group: A multicenter study of IgA nephropathy in children. Kidney Int 22:643–652, 1982.CrossRefGoogle Scholar
  11. 11.
    Kerr KK, Makker SP, Moorthy B: IgA nephropathy in children (Berger’s disease): a clinicopathologic study in children. Int J Pediatr Nephrol 4:11–18, 1983.Google Scholar
  12. 12.
    Mnery PT, Mdams AJ, West CD: Glomerular morphology, natural history and treatment of children with IgA nephropathy. In: Kincaid-Smith P, Mathew TH, Becker EL (eds) Glomerulonephritis. New York: John Wiley and Sons, 1973, pp 305–320.Google Scholar
  13. 13.
    Beukhof JR, Ockhuizen TH, Halie LM, Westra J, Beelen JM, Donker AJM, Hoedemaeker P, Van der Hem GK: Subentities within adult primary IgA-nephropathy. Clin Nephrol 22:195–199, 1984.PubMedGoogle Scholar
  14. 14.
    Hood SA, VelosA, Holley KE, Donadio JFJr: IgA-IgG nephropathy: predictive indices of progressive disease. Clin Nephrol 16:55–62, 1981.PubMedGoogle Scholar
  15. 15.
    Okada M, Tsuchida H, Yamamoto S: Familial mesangial IgA nephropathy, In: Yoshitoshi Y, Ueda Y (eds) Glomerulonephritis. Baltimore: University Park Press, 1979, pp 201–223.Google Scholar
  16. 16.
    Nakahara C, Aosai F, Hasegawa O, Ito H, Matsuo N, Hajikano H, Sakaguchi H: IgA nephropathy in children: a modified view of clinico-pathological characteristics. Pediatr Res 14:995(A), 1980.Google Scholar
  17. 17.
    Ohno J: Discussion, pp 133–134. In: Glassock RJ, Kurokawa K: IgA nephropathy in Japan. Am J Nephrol 5:127–137, 1985.Google Scholar
  18. 18.
    Hogg RJ, Silva FG: IgA nephropathy: natural history and prognostic indicators in children. Contrib Nephrol 40:214–221, 1984.PubMedGoogle Scholar
  19. 19.
    Tolkoff-Rubin NE, Cosimi AB, Fuller T, Rubin RH, Colvin RB: IgA nephropathy in HLA-identical siblings. Transplantation 26:430–433, 1978.PubMedCrossRefGoogle Scholar
  20. 20.
    Sabatier JC, Genin C, Assenat H, Colon S, Ducret F, Berthoux FC: Mesangial IgA glomerulonephritis in HLA-identical brothers. Clin Nephrol 11:35–38, 1979.PubMedGoogle Scholar
  21. 21.
    Berger J: Idiopathic mesangial IgA, In: Hamburger J, Crosnier J, Grunfeld J-P (eds) Nephrology. New York: John Wiley and Sons, 1979, pp 535–541.Google Scholar
  22. 22.
    Katz A, Karanicolas S, Falk JA: Family study in IgA nephritis: a possible role of HLA antigens. Transplantation 29:505–506, 1980.PubMedCrossRefGoogle Scholar
  23. 23.
    Montoliu J, Darnell A, Torras A, Ercilla G, Valles M, Revert L: Familial IgA nephropathy: report of two cases and brief review of the literature. Arch Intern Med 140:1374–1375, 1980.PubMedCrossRefGoogle Scholar
  24. 24.
    Sinniah R, Javier AR, Ku G: The pathology of mesangial IgA nephritis with clinical correlation. Histopathology 5:469–490, 1981.PubMedCrossRefGoogle Scholar
  25. 25.
    Rambausek M, Seelig HP, Andrassy K, Waldherr R, Kehry I, Lenhard V, Ritz E: Mesangial IgA-glomerulonephritis. Dtsch Med Wochenschr 108:125–130, 1981.CrossRefGoogle Scholar
  26. 26.
    Kashiwabara H, Shishido H, Tomura S, Tuchida H, Miyama T: Strong association between IgA nephropathy and HLA-DR4 antigen. Kidney Int 22:377–382, 1982.PubMedCrossRefGoogle Scholar
  27. 27.
    Wyatt RJ, Julian BA, Weinstein A, Rothfield NF, Mean RH: Partial H (B1H) deficiency and glomerulonephritis in two families. J Clin Immunol 2:110–117, 1982.PubMedCrossRefGoogle Scholar
  28. 28.
    Hene RJ, De Glas-Vos JW, Valentijn R, Gmelig Mayling FC, Krediet RT, Kater L: Aspects serologiques et genetiques dans deux families atteintes de néphropathie primitive á IgA. Nephrologie 3:94A, 1982.Google Scholar
  29. 29.
    Egido J, Balsco R, Sancho J, Lozano L, Gutierrez-Millet V: Immunological studies in a familial IgA nephropathy. Clin Exp Immunol 54:532–538, 1983.PubMedGoogle Scholar
  30. 30.
    Feehally J, Dyer PA, Davidson JA, Harris R, Mallick NP: Immunogenetics of IgA nephropathy: experience in a UK centre. Dis Markers 2:493–500, 1984.Google Scholar
  31. 31.
    Julian BA, Quiggins PA, Thompson JS, Woodford SY, Gleason K, Wyatt RJ: Familial IgA nephropathy: evidence of an inherited mechanism of disease. N Engl J Med 312:202–208, 1985.PubMedCrossRefGoogle Scholar
  32. 32.
    Sinniah R: Occurrence of mesangial IgA and IgM deposits in a control necropsy population. J Clin Pathol 36:276–279, 1983.PubMedCrossRefGoogle Scholar
  33. 33.
    Sakai H, Nomoto Y, Arimori S, Komori K, Inouye H, Tsuji K: Increase of IgA-bearing peripheral blood lymphocytes in families of patients with IgA nephropathy. Am J Clin Pathol 72:452–456, 1979.PubMedGoogle Scholar
  34. 34.
    Egido J, Blasco RA, Sancho J, Hernando L: Immunological abnormalities in healthy relatives of patients with IgA nephropathy. Am J Nephrol 5:14–20, 1985.PubMedCrossRefGoogle Scholar
  35. 35.
    Berthoux FC, Genin C, Gagne A, Le Petit JC, Sabatier JC: HLA B35 antigen and mesangial IgA glomerulonephritis: a poor prognosis marker? Proc Eur Dial Transplant Assoc 16:551–555, 1979.PubMedGoogle Scholar
  36. 36.
    Lopez Trascasa M, Egido J, Sancho J, Hernando L: IgA glomerulonephritis (Berger’s disease): evidence of high serum levels of polymeric IgA. Clin Exp Immunol 42:247–254, 1980.Google Scholar
  37. 37.
    Nomoto Y, Sakai H, Arimori S: Increase of I-bearing lymphocytes in peripheral blood from patients with IgA nephropathy. Am J Clin Pathol 71:158–160, 1979.PubMedGoogle Scholar
  38. 38.
    Egido J, Blasco R, Sancho J, Lozano L, Sanchez-Crespo M, Hernando L: Increased rates of polymeric IgA synthesis by circulating lymphoid cells in IgA mesangial glomerulonephritis. Clin Exp Immunol 47:309–316, 1982.PubMedGoogle Scholar
  39. 39.
    Emancipator SN, Gallo GR, Lamm ME: Experimental IgA nephropathy induced by oral immunization. J Exp Med 157:572–582, 1983.PubMedCrossRefGoogle Scholar
  40. 40.
    Valentijn RM, Kauffmann R, Brutel de la Riviere G, Daha M, Vanes LA: Presence of circulating macromolecular IgA in patients with hematuria due to primary I nephropathy. Am J Med 74:375–381, 1983.PubMedCrossRefGoogle Scholar
  41. 41.
    Lesavre PH, Pigeon M, Bach JF: Analysis of circulating IgA and detection of immune complexes in primary IgA nephropathy. Clin Exp Immunol 48:61–69, 1983.Google Scholar
  42. 42.
    Hall RP, Stachura I, Cason J, Whiteside TL, Lawley TJ: IgA-containing circulating immune complexes in patients with IgA nephropathy. Am J Med 74:56–63, 1983.PubMedCrossRefGoogle Scholar
  43. 43.
    Egido J, Blasco R, Lozano L, Sancho J, Garcia-hoyo R: Immunological abnormalities in tonsils of patients with IgA nephropathy: inversion of the ratio of IgA:IgG bearing lymphocytes and increased polymeric IgA synthesis. Clin Exp Immunol 57:101–106, 1984.PubMedGoogle Scholar
  44. 44.
    Westberg NG, Baklien K, Schmekel B, Gillberg R, Brandtzaeg P: Quantitation of immunoglobulin-producing cells in small intestinal mucosa of patients with IgA nephropathy. Clin Immunol Immunopathal 26:442–445, 1983.CrossRefGoogle Scholar
  45. 45.
    Endoh M, Suga T, Miura M, Tomino Y, Nomoto Y, Sakai H: In vivo alteration of antibody production in patients with IgA nephropathy. Clin Exp Immunol 57:564–570, 1984.PubMedGoogle Scholar
  46. 46.
    Egido J, Blasco R, Sancho J, Lozano L: T-cell dysfunctions in IgA nephropathy: specific abnormalities in the regulation of IgA synthesis. Clin Immunol Immunopathal 26:201–212, 1983.CrossRefGoogle Scholar
  47. 47.
    Rothschild E, Chatenoud L: T cell subset modulation of immunoglobulin production in IgA nephropathy and membranous glomerulonephritis. Kidney Int 25:557–564, 1984.PubMedCrossRefGoogle Scholar
  48. 48.
    Sakai H, Endoh M, Tomino Y, Nomoto Y: Increase of IgA-specific helper Ta cells in patients with IgA nephropathy. Clin Exp Immunol 50:77–82, 1982.PubMedGoogle Scholar
  49. 49.
    Adachi M, Yodo, Masuda T, Takatsuki K, Uchino H: Altered expression of lymphocyte Fca receptor in selective IgA deficiency and IgA nephropathy. J Immunol 131:1246–1251, 1985.Google Scholar
  50. 50.
    Endoh M, Sakai H, Nomoto Y, Tomino Y, Kaneshige H: IgA-specific helper activity of Ta cells in human peripheral blood. J Immunol 127:2612–2613, 1981.PubMedGoogle Scholar
  51. 51.
    Sakai H, Nomoto Y, Arimori S: Decrease of IgA-specific suppressor T cell activity in patients with IgA nephropathy. Clin Exp Immunol 38:243–248, 1979.PubMedGoogle Scholar
  52. 52.
    Valentijn RM, Kauffmann RH, De la Reviere M, Daha MR, Van Es LA: Presence of circulating macromolecular IgA in patients with hematuria due to primary IgA nephropathy. Am J Med 74:375–381, 1983.PubMedCrossRefGoogle Scholar
  53. 53.
    Tomino Y, Sakai H, Miura M, Nomoto Y, Umehara K, Hashimoto K: Detection of antigenic substances in patients with IgA nephropathy. Contrib Nephrol 40:69–73, 1984.PubMedGoogle Scholar
  54. 54.
    Nagy J, Uj M, Szucs G, Trinn C, Burger T: Herpes virus antigens and antibodies in kidney biopsies and sera of IgA glomerulonephritic patients. Clin Nephrol 21:259–262, 1984.PubMedGoogle Scholar
  55. 55.
    Clarkson AR, Seymour AE, Chan YL, Thompson AJ, Woodroffe AJ: Clinical, pathological and therapeutic aspects of IgA nephropathy. In: Kincaid-Smith P, D’Apice AJF, Atkins RC (eds) Progress in glomerulonephritis. New York: John Wiley, 1977, pp 283–309.Google Scholar
  56. 56.
    Newkirk MM, Klein MH, Katz A, Fisher MM, Underdown BJ: Estimation of polymeric IgA in human serum: an assay based on binding of radiolabeled human secretory component with applications in the study of IgA nephropathy, IgA monoclonal gammopathy and liver disease. J Immunol 130:1176–1181, 1983.PubMedGoogle Scholar
  57. 57.
    Bene MC, Faure G, Duheill: IgA nephropathy: characterization of the polymeric nature of mesangial deposits by in vitro binding of free secretory component. Clin Exp Immunol 47:527–534, 1982.PubMedGoogle Scholar
  58. 58.
    Katz A, Newkirk MM, Klein MH: Circulating and mesangial IgA in IgA nephropathy. In: D’Amico G, Minnetti L, Ponticelli C (eds) IgA mesangial nephropathy. Basel: Karger, 1984, pp 74–79.Google Scholar
  59. 59.
    Splawski JB, Woodard CS, Denney RM, Goldblum RM: Rapid development of polymeric IgA in the serum of infants. Clin Res 31:902A, 1983.Google Scholar
  60. 60.
    Savilahti E: Immunoglobulin-containing cells in the intestinal mucosa and immunoglobulins in the intestinal juice in children. Clin Exp Immunol 11:415–425, 1972.PubMedGoogle Scholar
  61. 61.
    Haworth JC, Dilling L: Concentration of A globulin in serum, saliva and nasopharyngeal secretions of infants and children. J Lab Clin Med 67:922–933, 1966.PubMedGoogle Scholar
  62. 62.
    Delacroix DL, Liroux E, Vaerman JP: High proportion of polymeric IgA in young infants’ sera and independence between IgA size and IgA subclass distributions. J Clin Immunol 3:51–55, 1983.PubMedCrossRefGoogle Scholar
  63. 63.
    Hogg RJ, Silva FG: IgA nephropathy: natural history and prognostic indices in children. In: D’Amico G, Minnetti L, Ponticelli C (eds) IgA mesangial nephropathy. Basel: Karger, 1984, pp 214–221.Google Scholar
  64. 64.
    Valentijn RM, Radl J, Haaijman JJ, Vermeer BJ, Weening JJ, Kauffmann RH, Daha MR, Van Es LA: Circulating and mesangial secretory component-binding IgA-1 in primary IgA nephropathy. Kidney Int 26:760–766, 1984.PubMedCrossRefGoogle Scholar
  65. 65.
    Conley ME, Cooper MD, Michael AF: Selective deposition of immunoglobulin A1 in immunoglobulin A nephropathy, anaphylactoid purpura nephritis and systemic lupus erythematosus. J Clin Invest 66:1432–1436, 1980.PubMedCrossRefGoogle Scholar
  66. 66.
    Stockert RJ, Kressner MS, Collins JC, Sternlieb I, Morell AG: IgA interaction with the asialoglycoprotein receptor. Proc Natl Acad Sci USA 79:6229–6231, 1982.PubMedCrossRefGoogle Scholar
  67. 67.
    Conley ME, Arbeter A, Douglas SD: Serum levels of IgAl and IgA2 in children and in patients with IgA deficiency. Mol Immunol 20:977–981, 1983.PubMedCrossRefGoogle Scholar
  68. 68.
    Rifai A, Mannik M: Clearance of circulating IgA immune complexes is mediated by a specific receptor on Kupffer cells in mice. J Exp Med 160:125–137, 1984.PubMedCrossRefGoogle Scholar
  69. 69.
    Kater L, Jobsis AC, Baart de la Faille-Kuyper EH, Vogten AJM, Grijm R: Alcoholic hepatic disease: specificity of IgA deposits in liver. Am J Clin Pathol 71:51–57, 1979.PubMedGoogle Scholar
  70. 70.
    Berger J, Yaneva H, Nabarra B: Glomerular changes in patients with cirrohsis of the liver. Adv Nephrol 7:3–32, 1978.Google Scholar
  71. 71.
    Lawrence S, Pussel BA, Charlesworth J A: Mesangial IgA nephropathy: detection of defective reticulophagocytic function in vivo. Clin Nephrol 16:280–283, 1983.Google Scholar
  72. 72.
    Nicholls K, Kincaid-Smith P: Defective in vivo Fc- and C3b-receptor function in IgA nephropathy. Am J Kidney Dis 4:128–134, 1984.PubMedGoogle Scholar
  73. 73.
    Roccatello D, Coppo R, Piccoli G: Monocyte-macrophage system function in IgA nephropathy. Contrib Nephrol 40:130–136, 1984.PubMedGoogle Scholar
  74. 74.
    Evans DJ, Gwyn Williams D, Peters DK, Sissons JGP, Boulton-Jones JM, Ogg CS, Cameron JS, Hoffbrand BI: Glomerular deposition of properdin in Henoch-Schonlein syndrome and idiopathic focal nephritis. Br Med J 3:326–328, 1973.PubMedCrossRefGoogle Scholar
  75. 75.
    Tomino Y: Complement system in IgA nephropathy. Tokai J Exp Clin Med 5:14–22, 1980.Google Scholar
  76. 76.
    Gotze O, Muller-Eberhard HJ: The C3-activation system: an alternative pathway of complement activation. J Exp Med 134:905–1085, 1971.Google Scholar
  77. 77.
    Pfaffenbach G, Lamm ME, Gigli I: Activation of guinea pig alternative complement pathway by mouse IgA immune complexes. J Exp Med 155:231–247, 1982.PubMedCrossRefGoogle Scholar
  78. 78.
    Boakle RJ, Pruitt KM, Mestecky J: The interactions of human complement with interfacially aggregated preparations of human secretory IgA. Immunochemistry 11:543–548, 1974.CrossRefGoogle Scholar
  79. 79.
    Julian BA, Wyatt RJ, Morrow RG, Galla JH: Serum complement proteins in IgA nephropathy. Clin Nephrol 20:251–258, 1983.PubMedGoogle Scholar
  80. 80.
    Lagrue G, Branellec A, Intrator L, Moisy M, Sobel A: Evaluation du C3d dans les néphropathies glomérulaires chroniques primitives. Nouv Presse Med 8:1153–1156, 1979.PubMedGoogle Scholar
  81. 81.
    Wyatt RJ, Kanayama Y, Julian BA, Sugimoto S, Curd JG: C3 activation in IgA nephropathy. Kidney Int 27:226A, 1985.Google Scholar
  82. 82.
    Kincaid-Smith P, Nicholls K: Mesangial IgA nephropathy. Am J Kidney Dis 3:90–102, 1983.PubMedGoogle Scholar
  83. 83.
    Linné T, Aperia A, Broberger O, Bergstrand A, Bohman S-O, Rekola S: Course of renal function in IgA glomerulonephritis in children and adolescents. Acta Paediatr Scand 71:735–743, 1982.PubMedCrossRefGoogle Scholar
  84. 84.
    Robson A: Pediatric perspectives. Am J Kidney Dis 2:566–567, 1983.Google Scholar
  85. 85.
    Southwest Pediatric Nephrology Study Group: Association of IgA nephropathy with steriod-responsive nephrotic syndrome. Am J Kidney Dis 5:157–164, 1985.Google Scholar
  86. 86.
    Mustonen J, Pasternack A, Rantala I: The nephrotic syndrome in IgA glomerulonephritis: response to corticosteriod therapy., Clin Nephrol 20:172–176, 1983.PubMedGoogle Scholar
  87. 87.
    Andreoli SP, Yum MN, Bergstein JM: IgA nephropathy in children: significance of glomerula basement membrane deposition of I. Am J Nephrol 6:28–33, 1986.PubMedCrossRefGoogle Scholar
  88. 88.
    Levy M, Gonzales-Burchard S, Broyer M, Dommergues J-P, Foulard M, Sorez J-P, Habib R: Outcome of Berger disease in children. Medicine 64:157–180, 1985.PubMedGoogle Scholar
  89. 89.
    Lagrue G, Sadreux T, Laurent J, Hirbec G: Is there a treatment of mesangial IgA glomerulonephritis [letter to the editor]. Clin Nephrol 16:161, 1981.PubMedGoogle Scholar
  90. 90.
    Hene RJ, Valentijn RM, Kater L: Plasmapheresis in nephropathy of Henoch-Schônlein purpura and primary IgA nephropathy. Kidney Int 22:409A, 1982.Google Scholar
  91. 91.
    Bergstein J: IgA nephropathy [letter to the editor]. Clin Nephrol 9:258–259, 1978.PubMedGoogle Scholar
  92. 92.
    Hamazaki T, Tateno S, Shishido H: Eicosapentaenoic acid and IgA nephropathy. Lancet 1:1017–1018, 1984.PubMedCrossRefGoogle Scholar

Copyright information

© Martinus Nijhoff Publishing, Boston 1987

Authors and Affiliations

  • Ronald J. Hogg
  • Abdalla Rifai
  • Judy B. Splawski
  • Robert J. Wyatt

There are no affiliations available

Personalised recommendations